Qilu Hospital of Shandong University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1890-01-01

Employees: -

Market Cap: -

Website: https://www.qiluhospital.com

Clinical Trials

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Phase 2

Recruiting

Conditions: Squamous Non-small Cell Lung Cancer

Interventions: Drug: "Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin"

First Posted Date: 2022-02-17

Last Posted Date: 2022-02-17

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 46

Registration Number: NCT05243355

Locations: 🇨🇳
Shandong Cancer Hospital, Jinan, China
🇨🇳
Qilu hospital of Shandong univertisy, Jinan, Shandong, China

Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

Phase 1

Not yet recruiting

Conditions: Gastric Cancer Metastatic to Liver

Interventions: Drug: Thalidomide Combined With Chemotherapy and Monotherapy

First Posted Date: 2022-01-20

Last Posted Date: 2022-01-20

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 106

Registration Number: NCT05198856

A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer

Conditions: Prostate Cancer

First Posted Date: 2022-01-05

Last Posted Date: 2022-10-12

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 936

Registration Number: NCT05179707

Locations: 🇨🇳
Qilu hospital, Jinan, Shandong, China

The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy

Not Applicable

Conditions: Prostate Cancer

Interventions: Other: puncture stent-assisted transperineal prostate biopsy

First Posted Date: 2022-01-05

Last Posted Date: 2022-10-18

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 560

Registration Number: NCT05179720

Locations: 🇨🇳
Qilu hospital, Jinan, Shandong, China

Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM

Not Applicable

Not yet recruiting

Conditions: Lymph Node Excision
Colorectal Neoplasms Malignant
Chemoradiotherapy

Interventions: Procedure: Radical surgery with PALND
Procedure: Radical surgery without PALND

First Posted Date: 2021-11-22

Last Posted Date: 2021-11-22

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 40

Registration Number: NCT05129774

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma

Phase 2

Conditions: Locally Advanced or Metastatic Acral Malignant Melanoma

Interventions: Drug: Toripalimab and Anlotinib

First Posted Date: 2021-10-21

Last Posted Date: 2021-10-21

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 29

Registration Number: NCT05087602

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma

Conditions: Biliary Tract Carcinoma

Interventions: Drug: Surufatinib

First Posted Date: 2021-10-01

Last Posted Date: 2021-10-01

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 200

Registration Number: NCT05064852

A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism

Not Applicable

Conditions: Esophageal and Gastric Varices
Hypersplenism
Liver Cirrhosis

Interventions: Procedure: Endoscopic therapy
Procedure: Endoscopic therapy+ beta blockers
Procedure: Endoscopic therapy+PSE+Somatostatin
Procedure: Endoscopic therapy+ PSE+beta blockers
Procedure: Endoscopic therapy+ PSE
Procedure: Endoscopic therapy+Somatostatin

First Posted Date: 2021-09-24

Last Posted Date: 2022-03-02

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 368

Registration Number: NCT05055713

Locations: 🇨🇳
Qilu Hospital , Shandong University, Jinan, Shandong, China

Prediction of Postoperative Acute Kidney Injury in Patients With Acute Type A Aortic Dissection Using Cystatin C

Completed

Conditions: Aortic Dissection
Acute Kidney Injury

Interventions: Other: none postoperative acute kidney injury
Other: postoperative acute kidney injury

First Posted Date: 2021-09-10

Last Posted Date: 2023-08-03

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 249

Registration Number: NCT05039814

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

Noninvasive Ventilation for Chronic Heart Failure

Not Applicable

Conditions: Chronic Stable Heart Failure

Interventions: Device: Noninvasive ventilation

First Posted Date: 2021-09-05

Last Posted Date: 2021-09-05

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 150

Registration Number: NCT05034549

Locations: 🇨🇳
The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China
🇨🇳
Qilu Hospital, Shandong University, Jinan, Shandong, China
🇨🇳
Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy